Drugs / CSJ137
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02570854 | Sep 2015 → May 2020 | iron deficiency anemia | Novartis Pharmaceuticals | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CSJ137 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02570854 ↗ |
| Route | Intravenous | “Subjects receive the treatment via up to 30 minutes intravenous infusion.” NCT02570854 ↗ |